This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Rebecca Voelker

JAMA. 1999;282:1992-1994.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Vienna—In this city rich with the history of Mozart and Strauss, diverse stakeholders in the AIDS epidemic met recently to compose a new score for bringing prevention and treatment to poor nations ravaged by deadly HIV.

While this article highlights the four countries shown, nearly 85% of new HIV infections and 90% of all AIDS-related deaths occur throughout Africa. Therefore, says the Harvard AIDS Review, "Africa seems a fitting place to focus vaccine development efforts." (Credit: Jill Ghormley)

During the Third International Conference on Healthcare Resource Allocation for HIV/AIDS and Other Life-Threatening Illnesses, dozens of speakers from around the world pointed to inequities involving the epidemic, now nearly two decades old. Expensive drug combinations prolong and improve life for many with HIV infection in developed nations, but impoverished countries suffer staggering economic losses and sharp declines in lifespan from HIV. At the same time, ease and . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?